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Congenital hearing loss has been documented to occur in1 of 1000 live births, with over half of these casespredicted to be hereditary in nature.1 2 Most hereditary
hearing loss is inherited in a recessive manner, accounting for
approximately 85% of non-syndromic hearing loss (NSHL).
Deafness is an extremely genetically heterogeneous disorder,
shown by the fact that 33 loci for recessive NSHL and 39 loci
for dominant NSHL have been mapped to date (updated regu-
larly on the Hereditary Hearing Loss Homepage: http://dnalab-
www.uia.ac.be/dnalab/hhh/index.html). In populations with
increased levels of consanguinity, such as India,3 congenital
hearing loss is even higher. According to the 47th Round of the
National Sample Survey Organisation (NSSO) taken in 1991
(http://www.healthlibrary.com/), 3 242 000 subjects over the
age of 5 have a hearing disability, which is defined as a hear-
ing impairment of 60 decibels and above in the better ear to
total loss of hearing in both ears. Prelingual recessively inher-
ited deafness has long been recognised in India. A significant
number of the deafness loci have been discovered or found in
the Indian population, facilitated by the large extended fami-
lies and high rates of consanguinity. Seven deafness loci are
currently known to be associated with deafness in India.
These include DFNB3,4 DFNB5,5 DFNB6,6 DFNB7/B11,7
DFNB15,8 DFNB17,9 and DFNB18.10 In four of these seven
cases, the associated gene has been cloned: transmembrane
cochlear expressed gene 1 (TMC1) for DFNB7/B11,11 myosin
XVA (MYO15A) for DFNB3,4 12 transmembrane inner ear
expressed gene (TMIE) for DFNB6,13 and harmonin for
DFNB18.14
In many parts of the world, deafness associated with the
DFNB1 locus on chromosome 13q11 is the most prevalent.
Two genes localised to this chromosomal region have been
implicated in deafness, including connexin26 (Cx26, gene
symbol GJB2)15 and connexin30 (Cx30, GJB6).16 17 In popula-
tions in which the genetic epidemiology of deafness has been
evaluated, mutations in GJB2 are the single most frequent
cause of inherited deafness. In certain northern European and
Mediterranean populations, it accounts for 50% of childhood
deafness.18–20 Connexins are gap junction proteins that oligo-
merise as hexamers to form transmembrane channels called
connexons. Connexons from the cell membranes interdigitate
to form direct intercellular communications pathways, the gap
junction channels. Connexins have a highly conserved form of
transmembrane domains separating two extracellular loops
from a middle cytoplasmic loop and the N- and C-terminal
cytoplasmic ends. In the inner ear, connexin26 is expressed in
the supporting cells, stria vascularis, basement membrane,
limbus, and spiral prominence of the cochlea.21 The sensory
hair cells of cochlea allow potassium ions to pass through
during the mechanosensory transduction process of normal
hearing. These potassium ions are recycled across the
supporting cells and fibrocytes at the base of hair cells through
the gap junctions of the stria vascularis and back to the K+ rich
endolymph. It is believed that mutations in the GJB2 gene
would lead to complete or partial loss of function of the Cx26
protein, interfering with recycling of potassium ions and thus
hampering the normal process of hearing. Removal of Cx26 in
the epithelial network of the inner ear of mice does lead to
deafness in these mice, indicating that Cx26 gap junctions are
essential for cochlear function and cell survival.22
Many studies from various parts of the world have
documented the incidence of GJB2 mutations in the deaf
population. These include France,19 the United States,23
Israel,24 and, most recently, Lebanon,25 Greece,26 Austria,27
China,28 Brazil,29 and the Iranian30 and Palestinian
populations.31 Updates covering all the connexin26 mutations
are provided by the Connexin-Deafness Homepage (http://
www.crg.es/deafness/). Several of these studies included sub-
jects from the Indian subcontinent.15 19 32–34 However, none of
these reports provided a systematic study of the prevalence of
connexin26 mutations in the Indian population. In our study,
we ascertained 215 profoundly deaf subjects and character-
ised the GJB2mutations in this population.
METHODS
Subjects
Independently ascertained probands (n=215) were recruited
for the study. Probands with a family history of NSHL had at
least two hearing impaired subjects in the family. Sporadic
Key points
• Mutations in the connexin26 (GJB2) gene are a major
cause of non-syndromic recessive deafness in many
parts of the world.
• To analyse the contribution of connexin26 to non-
syndromic hearing loss in India, 215 severe to profound
hearing impaired subjects from various parts of the
country were analysed. Thirty-eight deaf subjects were
found to have biallelic mutations of GJB2. Three differ-
ent mutations, ivs1(+1)G→A, W24X, and W77X, were
found in this study.
• W24X was found to be the most commonly observed
mutation (18.1%). Its carrier frequency was estimated to
be 0.024 in a sample of 205 normal hearing subjects
analysed. Comparison of the GJB2 flanking markers
between W24X homozygotes and a control population
suggests the contribution of a founder effect for this
mutation.
• Six gene polymorphisms were observed, of which
R127H and V153I were the most common, as well as a
novel polymorphism, I111T. This is the first study to
report the prevalence of connexin26 and its mutations in
the Indian population and has direct implications for
genetic counselling in a country with high levels of con-
sanguinity and congenital deafness.
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cases of NSHL did not report any known hearing loss in their
families and were born to consanguineous marriages. A com-
plete clinical history of each affected subject was collected to
ensure that the hearing loss was not a result of infection,
acoustic trauma, ototoxic drugs, or premature birth. Ten ml of
blood was collected from each subject after written informed
consent. This project was approved by the Institutional
Bioethics Committee in India. Genomic DNA was extracted
using the phenol-chloroform method.35
Audiology
Hearing levels were measured by pure tone audiometry, which
included bone conduction. Hearing thresholds were obtained
between 250 Hz and 8000 Hz in a soundproof room. All
probands exhibited bilateral, severe to profound sensorineural
hearing loss.
Connexin26 mutation analysis
The coding exon of GJB2 (exon 2) was amplified with two sets
of overlapping primers: 1F (5′-TCT TTT CCA GAG CAA ACC
GC-3′) and 1R (5′-GAC ACG AAG ATC AGC TGC AG-3′); 2F (5′-
CCAGGC TGCAAGAACGTG TG-3′) and 2R (5′-GGG CAA TGC
GTT AAA CTG GC-3′).24 These two primer sets amplify DNA
fragments of 286 bp and 519 bp, respectively. Amplification of
the first (non-coding) exon and the flanking donor splicing site
was performed by using the Advantage-GC Genomic PCR kit
(Clontech) and PCR primers EXON 1A (5′-TCC GTA ACT TTC
CCA GTC TCC GAG GGA AGA GG-3′) and EXON 1M (5′-CCC
AAG GAC GTG TGT TGG TCC AGC CCC-3′).19 PCR was
performed with 150 ng genomic DNA, 25 pmol primers, 10
mmol/l Tris-Cl, 50 mmol/l KCl, 1.5 mmol/l MgCl2, 800 µmol/l
dNTPs, and 2.5 U Taq DNA polymerase (Gibco-BRL) in a total
reaction volume of 50 µl for 40 cycles (each cycle of 94°C for 30
seconds, 60°C (for 1F-1R primers) and 62°C (2F-2R primers) for
30 seconds and 72°C for 60 seconds). PCR products were
purified usingQiaquick columns (Qiagen) and cycle sequencing
was performed using 30 ng of the purified PCR product, 3.2
pmol of each primer, and 4 µl of the ABI Prism Bigdye termina-
tor cycle sequencing Ready reaction mix (Perkin Elmer, Applied
Biosystems) in a 10 µl final volume for 25 cycles. Following cycle
sequencing, the samples were purified with ethanol, precipi-
tated, resuspended in formamide, denatured at 95°C for five
minutes and loaded onto an ABI 3100 Genetic Analyzer
(Applied Biosystems/Hitachi). The sequence of each amplicon
was confirmed by sequencing in both directions. Alignments
and analysis were performed using Clustal X version 1.8 (http://
www.molbiol.ox.ac.uk/documentation/clustalx/clustalx.html).
Evolutionary analysis
The degree of conservation of the polymorphic residues was
analysed using ConSeq (http://conseq.bioinfo.tau.ac.il.), the
sequence only variant of Rate4Site, an algorithmic tool for the
identification of functional regions in proteins.36 This software
examines the closest sequence homologues of a given protein
and calculates the evolutionary rate at each amino acid site.
Slowly evolving residues are usually important for maintain-
ing the protein’s structure and function. The scores range
between 1 and 9, 1 being rapidly evolving (variable) sites and
9 being slowly evolving (evolutionarily conserved) sites.
W24X carrier frequency
A sample of 205 independently ascertained hearing subjects
was used to estimate W24X carrier frequency. To check for
presence of the W24Xmutation, restriction enzyme digestions
were performed on the PCR products obtained using primers
1F and 1R mentioned above. The presence of the W24X muta-
tion introduces an AluI restriction site. AluI digestion of DNA
derived from unaffected subjects produced a single fragment
Table 1 GJB2 mutations in Indian probands with prelingual, bilateral hearing loss
Mutation Effect
Homozygotes Heterozygotes Compound heterozygotes
Allele frequency
among deafFamilial Sporadic Familial Sporadic Familial Sporadic
Ivs1(+1)G→A No transcript 0 0 0 0 1 0 0.002
71G→A W24X 28 8 3 2 1 0 0.181
231G→A W77X 1 0 0 0 0 0 0.005
Figure 1 Connexin26 phenotypes and genotype. (A)
Representative hearing thresholds of probands with GJB2 mutations.
Only thresholds for the better ear in each case are shown. The
horizontal axis shows tone frequency (Hz) and the vertical axis
displays hearing level (dB). (B) Sequence analysis of GJB2. The
upper panel shows the normal gene sequence and the lower panel
shows the sequence of a subject with the W24X/W24X mutation.
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of 286 bp,W24X homozygotes produced two fragments of 182
bp and 104 bp, and W24X heterozygotes produced three frag-
ments of 286 bp, 182 bp, and 104 bp.
Mutation age
The age of the W24X mutation was calculated using the equa-
tion Pmo-Po= (1-Po)e
-ct where Pmo is the frequency of marker
allele O on all chromosomes bearing the mutation M, Po is the
frequency of marker allele O on all chromosomes in the popu-
lation, c is the recombination rate per generation, and t is the
number of generations.37 Values of the parameters used were:
Pmo = 0.780, Po = 0.324, and c = 0.001.
Genotyping
To examine haplotypes associated with the common GJB2
mutations observed, genotyping was performed for the mark-
ers D13S141, D13S175, and D13S143 flanking the GJB2 gene.
This analysis was performed for the 36 independently
ascertained probands who were homozygous for the W24X
mutation and in 205 hearing subjects. PCR for the markers
was performed using fluorescently labelled reverse primers.
Genotyping was done using an ABI 3100 Genetic Analyzer and
analysis performed using Genotyper (version 3.7).
RESULTS
Mutation identification
Independently ascertained probands (n=215) from southern
and western parts of India were collected from the ages of 1-20
years. Hearing loss was reported to be from birth, without any
other accompanying clinical features. The hearing loss was con-
firmed by audiological testing in a soundproof room. Affected
subjects exhibited severe to profound hearing loss in both ears.
Fig 1A shows the pure tone hearing thresholds for hearing
impaired subjects. The entire coding region of GJB2 was
sequenced in the 215 probands. Single affected members were
from consanguineous marriages (n=70) and the remainder
belonged to families with a history of hearing loss (n=145). A
total of three different mutations, ivs1(+1)G→A, W24X, and
W77X, were found in this representative Indian population
(table 1); ivs1(+1)G→A is a mutation in the splice donor of
intron 1, corresponding to –3170 G→A relative to the AUG
translation initiating codon.A previous study has indicated that
the ivs1(+1)G→A allele is not transcribed or is extremely
unstable.31 A G→A transition at nucleotide 71 forms a nonsense
mutation at tryptophan 24 (W24X) (fig 1B). W24 is present in
the first transmembrane (TM1) domain of Cx26 (fig 2A). Incor-
poration of a stop codon at this position results in the formation
of a protein that is just one-tenth the length of the wild type
Figure 2 Connexin26 mutations
in India. (A) Schematic
representation of the connexin26
protein. The location of the
mutations identified are indicated.
(B) Amino acid conservation
analysis of connexin26. Residue
conservation scores, calculated
using the ConSeq server from 52
homologous sequences in the
Swiss-Prot database,45 are colour
coded onto the sequence of
connexin26 (see key). W24X and
W77X, mutations associated with
deafness, are indicated by aster-
isks; polymorphisms are indicated
by arrows.
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protein. A G→A transition at nucleotide 231 forms a nonsense
mutation at tryptophan 77 (W77X). W77 is present in the sec-
ond transmembrane (TM2) domain of Cx26 (fig 2A). Incorpo-
ration of a stop codon at both these positions is predicted to
result in a truncated protein with a complete loss of function.
W24X was the most common mutation seen in the
probands; 36 probands were homozygous and six probands
were heterozygous for this mutation. One proband was homo-
zygous for the W77X mutation. All the probands who were
heterozygous for mutations in GJB2 were typed for mutations
in the non-coding exon of GJB2. One of the probands was
heterozygous for both W24X and ivs1(+1)G→A. Further-
more, we identified five deaf subjects with a W24X hetero-
zygous mutation; they may be deaf as a result of an unidenti-
fied connexin26 mutation or mutations in another gene
altogether.
In addition to these deafness causing mutations, six
polymorphisms were observed. These were V27I, I111T, E114G,
R127H, V153I, and R165W. Their allele frequencies were
estimated among the deaf subjects (n=215) and among
hearing subjects (n=60) (table 2). R127H was found to be the
most common polymorphism among the deaf and hearing sub-
jects (table 2) and was previously identified in one deaf
person.38 In this case, an arginine is replaced by histidine in the
middle cytoplasmic loop. Another commonly observed poly-
morphismwas V153I,where a valine is replaced by isoleucine in
TM3.A novel polymorphism, I111T,was also observed,where an
isoleucine is replaced by a threonine. The degree of conservation
of the polymorphic residues in Cx26 was analysed using
ConSeq, which assigns amino acid conservation grades in the
range of 1-9, where 9 is maximal conservation and 1 is minimal
conservation, that is, highly variable (fig 2B).
W24X carrier frequency
In order to determine the carrier frequency of the W24X
mutation, 205 hearing subjects were screened for this
mutation. The presence of the W24X mutation introduces an
AluI restriction site. Unaffected subjects, W24X homozygotes,
and W24X heterozygotes can be differentiated based on the
size of the fragments obtained after digestion with AluI (see
Methods). Five out of these 205 subjects were heterozygous
for the W24X mutation, implying a carrier frequency of 0.024
(5/205).
W24X founder effect and age of the mutation
To test if the high frequency of theW24Xmutant alleles in this
sample is a result of a founder effect, we characterised three
flanking markers, D13S141, D13S143, and D13S175, in 36
probands homozygous for W24X and analysed the allele
frequencies of these markers in 205 controls (table 3). The
June 2002 freeze of the UCSC Human Genome Project Work-
ing Draft Assembly (http://genome.ucsc.edu/) estimates the
distance from D13S141, D13S175, and D13S143 to be 38.5 kb
centromeric, 84.7 kb telomeric, and 1.5 Mb telomeric to GJB2,
respectively. For the marker D13S141, the 123 allele is the
most common in both affected subjects and controls, with no
significant difference (χ2=3.49, df 1, p=0.062) in allele
frequency (table 3). Similarly, for the marker D13S143, located
furthest from GJB2 out of the three, the 126 allele is the most
common in both affected subjects and controls, with no
significant difference (χ2=0.51, df 1, p=0.475) in allele
frequency (table 3). For D13S175, the 100 allele is the most
common allele in 36 W24X homozygous probands (allele fre-
quency = 0.78), whereas the frequency of this allele in the
control population is lower (allele frequency = 0.324) (table
3). This difference in allele frequency between the affected
subjects and controls is statistically significant (χ2=45.62, df 1,
p=0.000), suggesting a founder effect for this mutation in the
Indian deaf population. The age of the W24X mutation was
calculated (see Methods) to be 7880 years (394 generations
with each generation of 20 years).
DISCUSSION
This study is the first of its kind in India, describing the preva-
lence of connexin26mutations in the Indian population. Up to
now, studies have included small numbers of subjects from
India in the search for causative genes for deafness other than
connexin26. The mutations in the coding region (W24X,
W77X) described in this report have been found previously in
a few subjects from the Indian subcontinent, including India,
Pakistan, Bangladesh, and Sri Lanka,15 32 34 whereas
ivs1(+1)G→A is reported from India for the first time.We did
not find the 35delG or 167delT mutations, which are very
common in European and Ashkenazi Jewish populations,
with carrier frequencies as high as 2-4%.38–41 Between 35-50%
of congenital cases of deafness in southern Europe and the
United States have biallelic GJB2 mutations,19 23 38 whereas
only 17.7% of congenital deaf probands in India have biallelic
GJB2 mutations. Therefore we predict that there will be addi-
tional deafness causing genes that are common in India, other
than those already found. In a study performed on nuclear,
consanguineous families from Tamil Nadu, India, the total
number of deafness genes was estimated to be 57.42
We identified several amino acid changes that we defined as
polymorphisms since they were present in both the hearing
and deaf population.We used Conseq, an algorithmic tool that
calculates the evolutionary rate at each amino acid site, to
analyse all the polymorphisms. I111T, E114G, R127H, and
R165W are predicted to cause no functional changes, since the
wild type amino acids at these positions are all variable.
Although V27I and V153I are conserved, they too are
predicted to be polymorphisms since these are conservative
changes. Two recent reports evaluated the function of gap
junction channels by transfection of the R127H mutation into
HeLa cells. In one case, R127H behaves like wild type
connexin26,43 and in the second, while it appears to form gap
junctions as observed by immunolocalisation, activity of the
gap junction is reduced.44 In the Indian hearing population,
R127H was found at a high frequency, strongly suggesting
that this is not a causative mutation for deafness.
Among the deaf subjects, five probands were heterozygous
for the W24X mutation. The cause of deafness in these
Table 2 Summary of gene polymorphisms detected and their frequencies
Polymorphism
Homozygous
(among deaf
subjects)
Heterozygous
(among deaf
subjects)
Allele frequency
among deaf
subjects (215)
Homozygous
(among hearing
subjects)
Heterozygous
(among hearing
subjects)
Allele frequency
among hearing
subjects (60)
V27I 0 1 0.002 0 0 0
I111T 0 1 0.002 0 0 0
E114G 0 1 0.002 0 0 0
R127H 10 33 0.123 3 15 0.175
V153I 0 16 0.037 2 3 0.058
R165W 0 3 0.007 0 0 0
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subjects could be because of several reasons. The first
possibility is that they are deaf as a result of mutations in
another gene altogether and they are coincidental carriers.
Five of 215 deaf subjects being heterozygous for W24X is not
significantly different from the carrier frequency of five out of
205 for the mutation among hearing subjects. The second
possibility is the existence of another mutation in the gene’s
promoter or unexplored regulatory regions. The third possi-
bility is the implication of another connexin gene (for exam-
ple, GJB616 17), that is, digenic origin of hearing loss, which
could be related to the putative formation of heteromeric con-
nexons or heterotypic channels. The GJB6 deletion was not
examined in these cases.
Haplotype analysis of markers flanking the GJB2 gene
shows that the most common mutation found in the Indian
population,W24X, is most probably a founder effect.While we
were unable to make a conclusion regarding the random or
founder effect nature of theW24Xmutation with the D13S141
and D13S143 flanking markers, results from the D13S175
marker do make this possibility highly likely.
The number of W24X mutations was found to be high,
comprising over 95% of the GJB2 mutations found in this
sample. The carrier frequency was 0.024, comparable to the
carrier frequency of the 35delG and 167delT GJB2 mutations
in other populations.38–41 Identifying this mutation in infants
would help in the early diagnosis of deafness, so that various
intervention strategies could be implemented at an early
stage, such as rehabilitation (for example, learning sign
language) and fitting of hearing aids, thus avoiding a period of
time when the child has little or no auditory stimulation. This
mutation can be identified by sequencing and can be easily
screened by the restriction enzyme assay we described in a
clinical setting. In a country such as India, with high levels of
consanguinity and congenital deafness, this assay can be
implemented easily and would directly benefit genetic
counselling and early rehabilitation in the hearing impaired
population.
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